| Cg Oncology, Inc. | 1.89M | US$134M | 22.1% |
| Tango Therapeutics, Inc. | 3.23M | US$95.7M | 15.8% |
| Revolution Medicines, Inc. | 242K | US$45.3M | 7.5% |
| Liquidia Corporation | 257K | US$20.5M | 3.4% |
| Enliven Therapeutics, Inc. | 365K | US$18.5M | 3.1% |
| Abivax Sa | 111K | US$14.8M | 2.4% |
| Avalo Therapeutics, Inc. | 771K | US$14.2M | 2.4% |
| Mirum Pharmaceuticals, Inc. | 110K | US$12.9M | 2.1% |
| Assembly Biosciences, Inc. | 433K | US$11.9M | 2.0% |
| Century Therapeutics, Inc. | 4.35M | US$10.7M | 1.8% |
| Cytokinetics, Incorporated | 118K | US$10.1M | 1.7% |
| Taysha Gene Therapies, Inc. | 1.5M | US$9.94M | 1.6% |
| Veradermics, Incorporated | 80,000 | US$9.84M | 1.6% |
| Arrivent Biopharma, Inc. | 247K | US$8.57M | 1.4% |
| Tarsus Pharmaceuticals, Inc. | 117K | US$7.91M | 1.3% |
| Xencor, Inc. | 368K | US$7.83M | 1.3% |
| Roivant Sciences Ltd. | 220K | US$7.79M | 1.3% |
| Damora Therapeutics, Inc. | 284K | US$7.4M | 1.2% |
| Axsome Therapeutics, Inc. | 28,826 | US$7.06M | 1.2% |
| Definium Therapeutics, Inc. | 149K | US$6.99M | 1.2% |
| Dianthus Therapeutics, Inc. | 64,723 | US$6.31M | 1.0% |
| Cogent Biosciences, Inc. | 148K | US$5.71M | 0.94% |
| Erasca, Inc. | 308K | US$5.64M | 0.93% |
| Protagonist Therapeutics, Inc. | 45,400 | US$5.57M | 0.92% |
| Minerva Neurosciences, Inc | 1M | US$5.56M | 0.92% |
| Editas Medicine, Inc. | 1.33M | US$4.31M | 0.71% |
| Cytomx Therapeutics, Inc. | 1.09M | US$4.07M | 0.67% |
| Eupraxia Pharmaceuticals, Inc. | 611K | US$4.04M | 0.67% |
| Sutro Biopharma, Inc. | 159K | US$3.79M | 0.63% |
| Relay Therapeutics, Inc. | 178K | US$3.33M | 0.55% |
| Celldex Therapeutics, Inc. | 86,664 | US$3.22M | 0.53% |
| Sagimet Biosciences Inc. - Series A | 404K | US$3.12M | 0.51% |
| Zai Lab Ltd. | 136K | US$2.92M | 0.48% |
| Sab Biotherapeutics, Inc. | 736K | US$2.87M | 0.47% |
| Madrigal Pharmaceuticals, Inc. | 4,973 | US$2.67M | 0.44% |
| Praxis Precision Medicines, Inc. | 7,540 | US$2.52M | 0.42% |
| Relmada Therapeutics, Inc. | 348K | US$2.41M | 0.40% |
| Agios Pharmaceuticals, Inc. | 56,900 | US$2.11M | 0.35% |
| Xenon Pharmaceuticals Inc. | 33,300 | US$2.08M | 0.34% |
| Savara, Inc. | 309K | US$1.9M | 0.31% |
| C4 Therapeutics, Inc. | 381K | US$1.78M | 0.29% |
| Vaxcyte, Inc. | 29,800 | US$1.78M | 0.29% |
| Celcuity Inc. | 16,252 | US$1.7M | 0.28% |
| Syndax Pharmaceuticals, Inc. | 77,930 | US$1.65M | 0.27% |
| Zentalis Pharmaceuticals, Inc. | 318K | US$1.45M | 0.24% |
| Leonabio, Inc. | 154K | US$1.42M | 0.23% |
| Ideaya Biosciences, Inc. | 37,865 | US$1.41M | 0.23% |
| Geron Corporation | 1.06M | US$1.35M | 0.22% |
| Corvus Pharmaceuticals, Inc. | 82,890 | US$1.24M | 0.20% |
| Spyre Therapeutics, Inc. | 13,300 | US$1.18M | 0.19% |
| Perspective Therapeutics, Inc. | 333K | US$1.13M | 0.19% |
| Onkure Therapeutics, Inc. | 241K | US$1.1M | 0.18% |
| Summit Therapeutics Inc. | 73,300 | US$1.09M | 0.18% |
| An2 Therapeutics, Inc. | 209K | US$1.01M | 0.17% |
| Contineum Therapeutics, Inc. | 60,541 | US$992K | 0.16% |
| Trevi Therapeutics, Inc. | 45,598 | US$833K | 0.14% |
| Voyager Therapeutics, Inc. | 230K | US$772K | 0.13% |
| Inventiva Sa | 200K | US$757K | 0.12% |
| Larimar Therapeutics, Inc. | 231K | US$704K | 0.12% |
| Inhibikase Therapeutics, Inc. | 347K | US$704K | 0.12% |
| Neurogene Inc. | 22,060 | US$694K | 0.11% |
| Krystal Biotech, Inc. | 1,774 | US$659K | 0.11% |
| Opus Genetics, Inc. | 143K | US$588K | 0.10% |
| Palisade Bio, Inc. | 272K | US$569K | 0.09% |
| Evolus, Inc. Common Stock | 78,057 | US$542K | 0.09% |
| Unicycive Therapeutics, Inc. | 103K | US$521K | 0.09% |
| Compass Therapeutics, Inc. | 233K | US$510K | 0.08% |
| Biocryst Pharmaceuticals, Inc. | 51,024 | US$510K | 0.08% |
| Bright Minds Biosciences Inc. | 6,395 | US$449K | 0.07% |
| Monte Rosa Therapeutics, Inc. | 16,800 | US$407K | 0.07% |
| Olema Pharmaceuticals, Inc. | 31,476 | US$394K | 0.06% |
| Milestone Pharmaceuticals Inc. | 270K | US$362K | 0.06% |
| Cue Biopharma, Inc. | 10,702 | US$338K | 0.06% |
| Mbx Biosciences, Inc. | 6,000 | US$331K | 0.05% |
| Beam Therapeutics Inc. | 8,804 | US$302K | 0.05% |
| Amylyx Pharmaceuticals, Inc. | 14,540 | US$261K | 0.04% |
| Stoke Therapeutics, Inc. | 7,745 | US$255K | 0.04% |
| Viking Therapeutics, Inc. | 7,404 | US$252K | 0.04% |
| Lipocine Inc. | 78,842 | US$202K | 0.03% |
| Corbus Pharmaceuticals Holdings, Inc. | 21,432 | US$201K | 0.03% |
| Promis Neurosciences Inc. | 10,600 | US$139K | 0.02% |
| Pmv Pharmaceuticals, Inc. | 53,569 | US$71,782 | 0.01% |
| Fulcrum Therapeutics, Inc. | 18,089 | US$66,206 | 0.01% |
| Pepgen Inc. | 0 | US$0 | 0.00% |
| Replimune Group, Inc. | 0 | US$0 | 0.00% |
| Septerna, Inc. | 0 | US$0 | 0.00% |
| Soleno Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Tyra Biosciences, Inc. | 0 | US$0 | 0.00% |
| United Therapeutics Corporation | 0 | US$0 | 0.00% |
| Verastem, Inc. | 0 | US$0 | 0.00% |
| Whitehawk Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Apogee Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Ascendis Pharma A/s | 0 | US$0 | 0.00% |
| Climb Bio, Inc. | 0 | US$0 | 0.00% |
| Context Therapeutics Inc. | 0 | US$0 | 0.00% |
| Cullinan Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Denali Therapeutics Inc. | 0 | US$0 | 0.00% |
| Disc Medicine, Inc. | 0 | US$0 | 0.00% |
| Edgewise Therapeutics, Inc. | 0 | US$0 | 0.00% |
| Eli Lilly And Company | 0 | US$0 | 0.00% |